BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4583 related articles for article (PubMed ID: 3932284)

  • 1. Transforming activity of the c-Ha-ras oncogene having two point mutations in codons 12 and 61.
    Sekiya T; Prassolov VS; Fushimi M; Nishimura S
    Jpn J Cancer Res; 1985 Sep; 76(9):851-5. PubMed ID: 3932284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential region for transforming activity of human c-Ha-ras-1.
    Sekiya T; Tokunaga A; Fushimi M
    Jpn J Cancer Res; 1985 Sep; 76(9):787-91. PubMed ID: 3932274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection and preliminary characteristics of the transforming gene (oncogene) of Ha-ras type in human stomach cancer].
    Kniazev PG; Schäfer R; Kalinovskiĭ VP; Matveev BV; Mel'nikov RA
    Mol Biol (Mosk); 1986; 20(6):1513-21. PubMed ID: 3027534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of the transforming Ha-ras gene in human melanoma, neuroblastoma and breast cancer cells].
    Kniazev PG; Schäfer R; Willecke K; Seits IF
    Vopr Onkol; 1985; 31(6):77-85. PubMed ID: 4024551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MNU-induced point mutation and activation of c-Ha-ras oncogene in cell lines derived from human pancreas explants.
    Maheshwari KK; Parsa I; Marsh WH
    Biochem Int; 1990; 20(1):117-25. PubMed ID: 2183801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation affecting the transforming activity of the human Ha-ras oncogene.
    Borrello MG; Pierotti MA; Bongarzone I; Donghi R; Mondellini P; Della Porta G
    Cancer Res; 1987 Jan; 47(1):75-9. PubMed ID: 2431768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
    Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
    J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
    Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
    Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
    Du Villard JA; Wicker R; Crespo P; Russo D; Filetti S; Gutkind JS; Sarasin A; Suárez HG
    Oncogene; 2000 Oct; 19(42):4896-905. PubMed ID: 11039907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ras oncogene activation in human ovarian carcinoma.
    van 't Veer LJ; Hermens R; van den Berg-Bakker LA; Cheng NC; Fleuren GJ; Bos JL; Cleton FJ; Schrier PI
    Oncogene; 1988 Feb; 2(2):157-65. PubMed ID: 3285294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Absence of point mutation in the 12th codon of the c-Ha-rasl transforming genes of human breast and stomach cancer, melanoma and neuroblastoma].
    Kniazev PG; Schäfer R; Willecke K; Seĭts IF
    Dokl Akad Nauk SSSR; 1985; 282(6):1487-9. PubMed ID: 4028949
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activated oncogenes in human tumors].
    Noguchi T; Adelaide J; Marics I; Raybaud F; de Lapeyrière O; Birnbaum D
    Bull Cancer; 1987; 74(6):607-21. PubMed ID: 3325106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on reversion of the human activated c-Ha-ras-transformed cells].
    Ogiso Y
    Hokkaido Igaku Zasshi; 1988 Sep; 63(5):687-97. PubMed ID: 3071518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
    Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
    Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay.
    Raybaud F; Noguchi T; Marics I; Adelaide J; Planche J; Batoz M; Aubert C; de Lapeyriere O; Birnbaum D
    Cancer Res; 1988 Feb; 48(4):950-3. PubMed ID: 3276402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Ha-ras containing 8-hydroxyguanine at codon 12 induces point mutations at the modified and adjacent positions.
    Kamiya H; Miura K; Ishikawa H; Inoue H; Nishimura S; Ohtsuka E
    Cancer Res; 1992 Jun; 52(12):3483-5. PubMed ID: 1596906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Integration of DNA oscillatory vector pSV neo to genome of NIH3T3: importance in investigations of transformation with c-Ha-ras oncogene].
    Burzyński A; Wiśniewski R; Wojciechowski W; Porwit-Bóbr Z
    Med Dosw Mikrobiol; 1994; 46(1-2):35-41. PubMed ID: 7967925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino-acid substitution at codon 13 of the N-ras oncogene in rectal cancer in a Japanese patient.
    Nitta N; Ochiai M; Nagao M; Sugimura T
    Jpn J Cancer Res; 1987 Jan; 78(1):21-6. PubMed ID: 3102434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 230.